Interaction between middle and inner ears in otitis media

REFERENCES

• Juhn SK, Jung TTK, Lin J, Lee YW, Giebink GS, Adams GL. The role of arachidonic acid metabolites in the pathogenesis of otitis media. Proceedings of Recent Advances in Otitis Media in Sendai 2001, pp. 65–70.
   Google Scholar
• Tuomanen E, Tomasz A, Hengstler B, Zak OJ. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. Infect Dis 1985; 151: 535—40.
   Google Scholar
• Tuomanen EL. Pathogenesis of pneumococcal inflammation: otitis media. Vaccine (Suppl) 2000; 19: S38–S40.
   Google Scholar
• Ripley-Petzoldt ML, Giebink GS, Juhn SK, Aeppli D, Tomasz A, Tuomanen E. The contribution of pneumococcal cell wall to pathogenesis of experimental otitis media. J Inf Dis 1988; 157: 245–55.
   PubMedGoogle Scholar
• Carlsen BD, Kawana C, Kawana A, Tomasz A, Giebink GS. Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae. Infect Immun 1992; 60: 2850–5.
   PubMedGoogle Scholar
• Jewett BS, Prazma JP, Hunter SE, Rose AS, Clarck JM, Sartor BR, et al. Systematic reactivation of otitis media in rat model. Otolaryngol Head Neck Surg 1999; 121: 7–12.
   PubMedGoogle Scholar
• Sato K, Quartey MK, Liebeler CL, Le CT, Giebink GS. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model. Infect Immun 1996; 64: 1140–5.
   PubMedGoogle Scholar
• Yellon RF, Leonard G, Maruch PT, Craven R, Carpenter RJ, Lehmann WB, et al. Characterization of cytokines. Infect Immun 1997; 65: 4411–18.
   PubMedGoogle Scholar
• Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A. Immunological characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol (Suppl) 1992; 101: 1–25.
   Google Scholar
• Juhn SK, Tolan CJ, Garvis WJ, Cross DS, Giebink GS. The levels of IL-1b in human middle ear effusions. Acta Otolaryngol (Stockh) Suppl, 1992; 493: 37—42.
   PubMedGoogle Scholar
• Forseni M, Melhus A, Ryan AF, Bagger-Sjoback D, Hultcrantz M. Detection and localization of interleukin-6 in the rat middle ear during experimental acute otitis media, using mRNA in situ hybridization and immunohisto-chemistry. Int JPediatr Otorhinolaryngol 2001; 57: 115–21.
   Google Scholar
• Hebda PA, Alper CM, Doyle WJ, Burckart GJ, Diven WF, Zeevi A. Up-regulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol 1998; 107: 501–7.
   PubMedGoogle Scholar
• Hebda PA, Piltcher O, Swarts JD, Alper CM, Swarts JD, Zeevi A, Doyle WJ. Cytokines profiles in a rat model of otitis media with effusion caused by Eustachian tube obstruction with or without Streptococcus pneumoniae infection. Laryngoscope 2002; 112: 1657–62.
   PubMedGoogle Scholar
• Mulhus A, Ryan F. Expression of cytokine genes during pneumococcal and non-typeable Haemophilus influenzae acute otitis media. Infect Immun 2000; 68: 4024–31.
   PubMedGoogle Scholar
• Sato K, Liebeler CL, Le CT, Giebink GS. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media. Infect Immun 1999; 69: 1943–6.
   Google Scholar
• Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, et al. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs present in middle ear effusion. Laryngoscope 1991; 101: 165–9.
   PubMedGoogle Scholar
• Li W, Lin J, Adams GL, Juhn SK. Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1/ìand TNF-a. Int JPediatr Otolaryngol 2000; 55: 85–91.
   Google Scholar
• Ryan AF, Bennet T. Nitric oxide contributes to control of effusion in experimental otitis media. Laryngoscope 2001; 111: 301–5.
   PubMedGoogle Scholar
• Ball SS, Prazma J, Dais GG, Rosbe KW, Pillsburry HC. Nitric oxide: a mediator of endotoxin-induced middle ear effusions. Laryngoscope 1996; 106: 1021–7.
   PubMedGoogle Scholar
• John EO, Russel PT, Nam BH, Jinn TH, Jung TT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001; 60: 55–8.
   PubMed Web of Science ®Google Scholar
• Juhn SK, Jung TTK, Lin J, Rhee CK. Effect of inflammatory mediators on middle ear pathology and inner ear function. Ann NY Acad Sci 1997; 830: 130—42.
   PubMed Web of Science ®Google Scholar
• Goycoolea MV, Muchow D, Schachern P. Experimental studies on round window structure: function and permeability. Laryngoscope 1988; 98: 1–20.
   PubMedGoogle Scholar
• McDermott JC, Fausti SA, Frey RH. Effects of middle-ear disease and cleft palate on high-frequency hearing in children. Audiology 1986; 25: 136–8.
   PubMedGoogle Scholar
• Lopponen H, Sorri M, Pekkala R, Penna J. Secretory otitis media and high-frequency hearing loss. Acta Otolaryngolo-gica (Suppl) 1992; 493: 99–107.
   PubMedGoogle Scholar
• Hunter LL, Margolis RH, Rykken JR, Le CT, Daly KA, Giebink GS. High frequency hearing loss associated with otitis media. Ear Hear 1996; 17: 1–11.
   PubMed Web of Science ®Google Scholar
• Margolis RH, Saly GL, Hunter L. High-frequency loss and wideband middle ear impedance in children with otitis media histories. Ear Hear 2000; 21: 206–11.
   PubMed Web of Science ®Google Scholar
• Morizono T, Giebink GS, Paparella MM, Sikora MA, Shea D. Sensorineural hearing loss in experimental purulent otitis media due to Streptococcus pneumoniae. Arch Otolaryngol 1985; 111: 794—8.
   PubMedGoogle Scholar
• Demaria TF. Localization of non-typeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental otitis media. Acta Oto-Laryngologica 1999; 119: 583—7.
   PubMed Web of Science ®Google Scholar
• Huang M, Dulon D, Schacht J. Outer hair cells as potential targets of inflammatory mediators. Ann Otol Rhin Laryngol (Suppl) 1990; 148: 35—8.
   PubMedGoogle Scholar
• Wang H, Xing C, Cai Y. Effect of experimental immuno-logical otitis media on inner ear. Chinese J Clin Otorhino-laryngol 1997; 11: 296—8.
   Google Scholar
• Stenqvist M, Anniko M, Rask-Andersen H. Middle ear mucosa changes following exposure to Pseudomonas aeruginosa exotoxin A. Eur Arch Otorhinolaryngol 1999; 256: 484—90.
   PubMed Web of Science ®Google Scholar
• Hodges KB, Penny JE, Brown RD, Henley CM. Scanning electron microscopy of cochlea in rats with Streptococcus pneumoniae otitis media. Arch Otolaryngol 1984; 10: 429— 36.
   Google Scholar
• Schachern PA, Paparella M, Hyberston R, Sano S, Duvall III AJ. Bacterial tympanogenic labyrinthitis, meningitis and sensorineural damage. Arch Otolaryngol Head Neck Surg 1992; 118: 53—7.
   PubMedGoogle Scholar
• Cook RD, Postma DS, Brinson GM, Prazma J, Pillsbury HC. Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection. J Otolaryng 1999; 28: 325—31.
   PubMedGoogle Scholar
• Comis SD, Osborne MP, Stephen J, Tarlow MJ, Hayward TL, Mitchell TJ, Bulnouis GL. Cytotoxic effect on hair cells of guinea pig cochlea produced by pneumolysin. Acta-Otolaryngol 1993; 113: 152—9.
   PubMed Web of Science ®Google Scholar
• Engel F, Blatz R, Kellner J, Palmer M, Weller U, Bhaki S. Breakdown of the RWM permeability barrier evoked by streptolysin O: possible etiologic role in development of sensorineural hearing loss in acute otitis media. Infect Immun 1995; 63: 1305—10.
   PubMed Web of Science ®Google Scholar
• Kubo T, Anniko M, Stenqvist M, Hsu W. Interleukin-2 affects cochlear function gradually but reversibly. J Otorhinolaryngol Relat Spec 1998; 60: 272—7.
   PubMed Web of Science ®Google Scholar
• Iguchi H, Anniko M. Interleukin 8 can affect inner ear function. J Otorhinolaryngol Relat Spec 1998; 60: 181—9.
   PubMed Web of Science ®Google Scholar
• Ichimiya I, Suzuki M, Hirano T, Mogi G. The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res 1999; 131: 128—34.
   PubMed Web of Science ®Google Scholar
• Ichimiya I, Yoshida K, Hirano T, Suzuki M, Mogi G. Significance of spiral ligament fibrocytes with cochlear inflammation. Int J Pediatr Otolaryng 2000; 56: 45–51.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Ischimiya I, Suzuki M, Mogi G. Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear Res 1999; 137: 155–9.
   PubMed Web of Science ®Google Scholar
• Hess A, Bloch W, Huverstuhl J, Su J, Stennert E, Addicks K, Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intra-tympanical endotoxin treatment. Brain Res 1999; 830: 113–22.
   PubMed Web of Science ®Google Scholar
• Sone M, Russle H, Canafax MM, Paparella MM. Expression of intercellular adhesion molecule-1 in rat inner ear due to bacterial otitis media. Ann Otol Rhinol Laryng 1999; 108: 648–52.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Jinnouchi K, Hess A, Michel O, Yagi T. Detection of apoptotic changes in the lipopolysaccharide (LPS)-treated cochlea of guinea pigs. Hear Res 2001; 158: 116–22.
   PubMedGoogle Scholar
• Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurol 2002; 23: 316–22.
   PubMed Web of Science ®Google Scholar
• Juhn SK, Lee S, Hunter B, Tsuprun V, Lee Y-W, Jurney W, Odland R. Characteristics of blood-labyrinth barrier. In: Santi PA, editor. ARO Abstracts. Daytona Beach (FL) 2003, pp. (Abstract 65, p. 17).
   Google Scholar
• Lau C, Billings P, Harris J, Keithley E. Effect of TNF-a on recruitment of cochlear inflammatory cells. In: Santi PA, editor, ARO Abstracts. Daytona Beach (FL) 2003, pp. Abstract 1053, p. 267.
   Google Scholar
• Hashimoto S, Billings P, Firestein GS, Harris JP, Keithley E. Contribution of innate immune response to cochlear inflammation. In: Santi PA, editor. ARO Abstracts. Daytona Beach (FL) 2003, pp. (Abstr 1051 p. 266).
   Google Scholar